MENU
+Compare
ALID
Stock ticker: OTC
AS OF
Aug 14 closing price
Price
$0.01
Change
-$0.00 (-0.00%)
Capitalization
1.28M

ALID Allied Corp. Forecast, Technical & Fundamental Analysis

Allied Corp is an international cannabis company with a mission to help people suffering from Post-Traumatic Stress Disorder (PTSD) by researching, creating, and producing targeted cannabinoid health solutions... Show more

ALID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALID with price predictions
Aug 25, 2025

ALID's Stochastic Oscillator is sitting in oversold zone for 22 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ALID moved above its 50-day moving average on August 25, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ALID crossed bullishly above the 50-day moving average on August 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 73 cases where ALID Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.208). P/E Ratio (0.000) is within average values for comparable stocks, (73.038). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.872). ALID has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (11.468) is also within normal values, averaging (41.709).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ALID’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALID’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
ALID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
1405 St. Paul Street
Phone
+1 877 255-4337
Employees
15
Web
https://www.allied.health
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTX63.970.17
+0.27%
Minerals Technologies
CNDT2.75-0.05
-1.79%
Conduent
MBLY13.81-0.34
-2.40%
Mobileye Global
IMDX2.49-0.10
-3.86%
Insight Molecular Diagnostics Inc
ELAB2.10-0.27
-11.39%
PMGC Holdings Inc

ALID and Stocks

Correlation & Price change

A.I.dvisor tells us that ALID and ABSCF have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALID and ABSCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALID
1D Price
Change %
ALID100%
N/A
ABSCF - ALID
16%
Poorly correlated
N/A
ARSUF - ALID
8%
Poorly correlated
N/A
APNHY - ALID
6%
Poorly correlated
-1.01%
YCBD - ALID
4%
Poorly correlated
+5.21%
ORGO - ALID
2%
Poorly correlated
-4.50%
More

Groups containing ALID

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALID
1D Price
Change %
ALID100%
N/A
Pharmaceuticals: Generic
industry (225 stocks)
8%
Poorly correlated
+0.23%